Astrid Hundebøll Torpe

The primary research focus is multiple myeloma, particularly within the rapidly advancing field of novel immunotherapies. This includes real-world evidence studies on advanced treatments such as bispecific antibodies and CAR-T therapy, based on both Danish and Nordic patient cohorts.

Additional research areas include infection epidemiology in myeloma and the evaluation of prophylactic strategies aimed at improving patient safety. There is active involvement in phase II and III clinical trials, spanning large international collaborations as well as investigator-initiated studies. Translational research efforts further include biomarker development for BCL-2–targeted therapy in patients with t(11;14) disease.

Currently an MD and PhD fellow at the Department of Hematology, Copenhagen University Hospital.

Contact: ahun0010@regionh.dk